213 related articles for article (PubMed ID: 12209040)
1. Does active treatment of rheumatoid arthritis limit disease-associated bone loss?
Dolan AL; Moniz C; Abraha H; Pitt P
Rheumatology (Oxford); 2002 Sep; 41(9):1047-51. PubMed ID: 12209040
[TBL] [Abstract][Full Text] [Related]
2. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
4. Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetry.
Szentpetery A; Heffernan E; Haroon M; Kilbane M; Gallagher P; McKenna MJ; FitzGerald O
Rheumatology (Oxford); 2016 May; 55(5):891-6. PubMed ID: 26850991
[TBL] [Abstract][Full Text] [Related]
5. Outcome of rheumatoid arthritis following adjunct statin therapy.
Das S; Mohanty M; Padhan P
Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
[TBL] [Abstract][Full Text] [Related]
6. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.
Solomon DH; Finkelstein JS; Shadick N; LeBoff MS; Winalski CS; Stedman M; Glass R; Brookhart MA; Weinblatt ME; Gravallese EM
Arthritis Rheum; 2009 Jun; 60(6):1624-31. PubMed ID: 19479876
[TBL] [Abstract][Full Text] [Related]
7. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.
Gough A; Sambrook P; Devlin J; Huissoon A; Njeh C; Robbins S; Nguyen T; Emery P
J Rheumatol; 1998 Jul; 25(7):1282-9. PubMed ID: 9676757
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
[TBL] [Abstract][Full Text] [Related]
9. Activity of rheumatoid arthritis and urinary pyridinoline and deoxypyridinoline.
Kameyama O; Nakahigashi Y; Nakao H; Uejima D; Tsuji H
J Orthop Sci; 2000; 5(4):385-9. PubMed ID: 10982689
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between wrist bone mineral density and synovitis, erosion by ultrasonography in female rheumatoid arthritis patients].
Wang Y; Geng Y; Deng XR; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):774-80. PubMed ID: 26474614
[TBL] [Abstract][Full Text] [Related]
11. Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study.
Wheater G; Elshahaly M; Naraghi K; Tuck SP; Datta HK; van Laar JM
PLoS One; 2018; 13(8):e0201527. PubMed ID: 30080871
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.
Verhoeven AC; Boers M; te Koppele JM; van der Laan WH; Markusse HM; Geusens P; van der Linden S
Rheumatology (Oxford); 2001 Nov; 40(11):1231-7. PubMed ID: 11709606
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.
Masamoto K; Otsuki B; Fujibayashi S; Shima K; Ito H; Furu M; Hashimoto M; Tanaka M; Lyman S; Yoshitomi H; Tanida S; Mimori T; Matsuda S
Eur Spine J; 2018 Feb; 27(2):406-415. PubMed ID: 29185111
[TBL] [Abstract][Full Text] [Related]
14. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
[TBL] [Abstract][Full Text] [Related]
15. The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid.
Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Wakitani S; Nakamura H
J Bone Miner Metab; 2014 Sep; 32(5):593-600. PubMed ID: 24233123
[TBL] [Abstract][Full Text] [Related]
16. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.
Dolan AL; Moniz C; Dasgupta B; Li F; Mackintosh C; Todd P; Corrigall V; Panayi GS
Arthritis Rheum; 1997 Nov; 40(11):2022-9. PubMed ID: 9365092
[TBL] [Abstract][Full Text] [Related]
17. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
[TBL] [Abstract][Full Text] [Related]
18. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C; Karlsson M; Akesson K; Jacobsson L
Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
[TBL] [Abstract][Full Text] [Related]
19. Trabecular bone density in premenopausal rheumatoid arthritis patients.
Kalla AA; Bewerunge L; Langley A; Meyers OL; Fataar AB
S Afr Med J; 2002 Jan; 92(1):62-8. PubMed ID: 11936021
[TBL] [Abstract][Full Text] [Related]
20. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
